Onderzoeker
Tom Vanden Berghe
- Disciplines:Biofysica, Moleculaire en celbiologie, Laboratoriumgeneeskunde, Microbiologie, Systeembiologie, Plantenbiologie, Medicinale en biomoleculaire chemie
Affiliaties
- Vakgroep Biomedische Moleculaire Biologie (Departement)
Lid
Vanaf1 okt 1999 → Heden
Projecten
1 - 5 of 5
- Onderzoek naar de immunoregulatorische eigenschappen van ferroptose in experimentele kankermodellenVanaf1 nov 2020 → HedenFinanciering: FWO mandaten
- Therapeutische verkenning van loodferroptoseremmers bij multiple sclerose - subsidie 2020Vanaf1 jan 2020 → 30 jun 2021Financiering: Stichtingen, fondsen e.d. met wetenschappelijk oogmerk
- Therapeutische verkenning van loodferroptoseremmers bij multiple scleroseVanaf1 jan 2019 → 31 dec 2020Financiering: Stichtingen, fondsen e.d. met wetenschappelijk oogmerk
- Gebaseerde nanodeeltjes ferroptose inductie voor de behandeling van neuroblastoma en glioblastomaVanaf1 jan 2019 → 31 dec 2021Financiering: Stichtingen, fondsen e.d. met wetenschappelijk oogmerk
- Studie van de in vivo rol van effector caspasen in (patho-)fysiologische modelsystemen.Vanaf1 okt 2007 → 30 sep 2013Financiering: BOF - Andere acties, FWO mandaten
Publicaties
11 - 20 van 104
- Novel iron oxide nanoparticles induce ferroptosis in a panel of cancer cell lines(2022)
Auteurs: Roberto Fernandez-Acosta, Claudia Iriarte-Mesa, Daniel Alvarez-Alminaque, Behrouz Hassannia, Bartosz Wiernicki, Alicia M. Diaz-Garcia, Peter Vandenabeele, Tom Vanden Berghe, Gilberto L. Pardo Andreu
- Luminescent human iPSC-derived neurospheroids enable modeling of neurotoxicity after oxygen-glucose deprivation(2022)
Auteurs: Elise Van Breedam, Aleksandra Nijak, Tamariche Buyle-Huybrecht, Julia Di Stefano, Marlies Boeren, Jonas Govaerts, Alessandra Quarta, Tine Swartenbroekx, Eva Jacobs, Rik Gijsbers, et al.
Pagina's: 550 - 569 - Viral dosing of influenza A infection reveals involvement of RIPK3 and FADD, but not MLKL(2021)
Auteurs: Teodora-Eugenia Oltean, Emily Van San, Tatyana Divert, Tom Vanden Berghe, Jonathan Maelfait, Nozomi Takahashi, Peter Vandenabeele
- Necroptosis signalling promotes inflammation, airway remodelling and emphysema in COPD(2021)
Auteurs: Zhe Lu, Hannelore Van Eeckhoutte, Gang Liu, Prema M Nair, Bernadette Jones, Caitlin Gillis, B. Christina Nalkurthi, Fien Verhamme, Tamariche Buyle-Huybrecht, Peter Vandenabeele, et al.
Pagina's: 667 - 681 - Ionizing radiation results in a mixture of cellular outcomes including mitotic catastrophe, senescence, methuosis, and iron-dependent cell death(2020)
Auteurs: Sandy Adjemian Catani, Teodora-Eugenia Oltean, Sofie Martens, Bartosz Wiernicki, Tom Vanden Berghe, Benjamin Cappe, Maria Ladik, Franck Riquet, Liesbeth Heyndrickx, Jolien Bridelance, et al.
- Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer(2020)
Auteurs: Maria Paula Roberti, Satoru Yonekura, Connie P. M. Duong, Marion Picard, Gladys Ferrere, Maryam Tidjani Alou, Conrad Rauber, Valerio Iebba, Christian H. K. Lehmann, Lukas Amon, et al.
Pagina's: 919 - 931 - Emerging immune and cell death mechanisms in stroke : saponins as therapeutic candidates(2020)
Auteurs: Laura García-Pupo, Emily Van San, René Delgado-Hernández, Tom Vanden Berghe, Wim Vanden Berghe
- Excessive phospholipid peroxidation distinguishes ferroptosis from other cell death modes including pyroptosis(2020)
Auteurs: Bartosz Wiernicki, Hanne Dubois, Yulia Y. Tyurina, Hulya Bayir, Valerian E. Kagan, Peter Vandenabeele, Tom Vanden Berghe
- Withaferin A : from ayurvedic folk medicine to preclinical anti-cancer drug(2020)
Auteurs: Behrouz Hassannia, Emilie Logie, Peter Vandenabeele, Tom Vanden Berghe, Wim Vanden Berghe
- Fatal lymphocytic cardiac damage in coronavirus disease 2019 (COVID-19) : autopsy reveals a ferroptosis signature(2020)
Auteurs: Werner Jacobs, Martin Lammens, Annelies Kerckhofs, Evy Voets, Emily Van San, Samya Van Coillie, Cedric Peleman, Matthias Mergeay, Sabriya Sirimsi, Veerle Matheeussen, et al.
Patenten
1 - 6 van 6
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- Targeting of Interleukin-1 and -18 in treatment of septic shock (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)